Casdin Capital, LLC
GeneDx Holdings Corp. · Director, 10% Owner
Casdin Capital, LLC is listed in filings as Director, 10% Owner at GeneDx Holdings Corp.. This profile follows SEC Form 4 activity through Jun 8, 2026, including sale activity and purchase activity. Recent filings connect the profile to GeneDx Holdings Corp. (WGS) and 2seventy bio, Inc. (TSVT). The current snapshot covers public activity from Jun 12, 2024 to Jun 8, 2026. Reported amounts are shown as $60.5M to $7.9M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $60M500k shares | SellAug 22, 2025 | $120.90 | $61.65 | |
| Disclosure amount unavailable500k shares | BuyMay 7, 2026 | -- | $61.65 | |
| Disclosure amount unavailable300k shares | BuyMay 8, 2026 | -- | $61.65 | |
| Disclosure amount unavailable50k shares | BuyMay 11, 2026 | -- | $61.65 | |
| $7M175k shares | BuyMay 18, 2026 | $42.55 | $61.65 | |
| $8M185k shares | BuyMay 19, 2026 | $42.60 | $61.65 | |
| $6M140k shares | BuyMay 20, 2026 | $43.81 | $61.65 | |
| $8M150k shares | BuyJun 4, 2026 | $56.44 | $61.65 |